CRP and cardiovascular disorder: Several studies have confirmed the role of subclinical inflammation in the course of atherosclerosis and have associated CRP levels with the metabolic syndrome (MS), type 2 diabetes mellitus (T2DM) and increased risk for cardiovascular disease (1,2).